JOEL LEWIS - President and CEO, Director at GALECTIN THERAPEUTICS INC

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
GALT on Nasdaq
All Insider Reports
All Insider Reports

JOEL LEWIS - trading volume in the past year for GALECTIN THERAPEUTICS INC

Holdings reported by JOEL LEWIS for GALECTIN THERAPEUTICS INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 776,260 $3,011,888 $3.88 05 Jan 2026 Direct
Restricted Stock Unit 100,000 $97,440 $1.16 16 Jan 2026 Direct Common Stock
Stock option (right to buy) 91,000 $96,197 $2.39 16 Jan 2026 Direct Common Stock
Common Stock 2,000 $8,320 $4.16 05 Jan 2026 as USTA custodian for a minor child

Transactions reported by JOEL LEWIS for GALECTIN THERAPEUTICS INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.